Correction: Discovery of novel 4-trifluoromethyl-2-anilinoquinoline derivatives as potential anti-cancer agents targeting SGK1.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
Works matching IS 13811991 AND DT 2025 AND VI 29 AND IP 3
Results: 51
1
2
Decarboxylative click cycloaddition: an emerging strategy towards substituted 1,2,3-triazole derivatives.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2811, doi. 10.1007/s11030-024-11014-4
- By:
- Publication type:
- Article
3
Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>@[Aminoglycol][Formate] as a new superparamagnetic nanocatalyst and [Aminoglycol][Formate] as a novel ionic liquid catalyst for preparation of new dimethyldihydropyrimido[4,5-b]quinolone derivatives.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2601, doi. 10.1007/s11030-024-11013-5
- By:
- Publication type:
- Article
4
Design, synthesis, and mechanism study of novel tetrahydroisoquinoline derivatives as antifungal agents.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2585, doi. 10.1007/s11030-024-11012-6
- By:
- Publication type:
- Article
5
Design, synthesis, and anti-breast cancer activity evaluation of novel 3-cyanopyridine derivatives as PIM-1 inhibitors.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2565, doi. 10.1007/s11030-024-11010-8
- By:
- Publication type:
- Article
6
Advancements of anticancer agents by targeting the Hippo signalling pathway: biological activity, selectivity, docking analysis, and structure–activity relationship.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2829, doi. 10.1007/s11030-024-11009-1
- By:
- Publication type:
- Article
7
Valencene as a novel potential downregulator of THRB in NSCLC: network pharmacology, molecular docking, molecular dynamics simulation, ADMET analysis, and in vitro analysis.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2543, doi. 10.1007/s11030-024-11008-2
- By:
- Publication type:
- Article
8
Design and investigation of novel iridoid-based peptide conjugates for targeting EGFR and its mutants L858R and T790M/L858R/C797S: an in silico study.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2517, doi. 10.1007/s11030-024-11007-3
- By:
- Publication type:
- Article
9
Exploring flavonoid derivatives as potential pancreatic lipase inhibitors for obesity management: An in silico and in vitro study.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2499, doi. 10.1007/s11030-024-11005-5
- By:
- Publication type:
- Article
10
Anti-inflammatory effects of resveratrol in treating interstitial cystitis/bladder pain syndrome: a multi-faceted approach integrating network pharmacology, molecular docking, and experimental validation.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2489, doi. 10.1007/s11030-024-11004-6
- By:
- Publication type:
- Article
11
A deep drug prediction framework for viral infectious diseases using an optimizer-based ensemble of convolutional neural network: COVID-19 as a case study.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2473, doi. 10.1007/s11030-024-11003-7
- By:
- Publication type:
- Article
12
Synthesis and antifungal activities of small molecule arylthiazolamine derivatives.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2463, doi. 10.1007/s11030-024-11002-8
- By:
- Publication type:
- Article
13
Destabilisation of Alzheimer's amyloid-β protofibrils by Baicalein: mechanistic insights from all-atom molecular dynamics simulations.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2445, doi. 10.1007/s11030-024-11001-9
- By:
- Publication type:
- Article
14
A potent dual inhibitor targeting COX-2 and HDAC of acute myeloid leukemia cells.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2433, doi. 10.1007/s11030-024-11000-w
- By:
- Publication type:
- Article
15
Modulating JAK2/STAT3 signaling by quercetin in Qiling Baitouweng Tang: a potential therapeutic approach for diffuse large B-cell lymphoma.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2407, doi. 10.1007/s11030-024-10999-2
- By:
- Publication type:
- Article
16
Design, synthesis and biological evaluation of thienopyridine derivatives as c-Met kinase inhibitors.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2391, doi. 10.1007/s11030-024-10998-3
- By:
- Publication type:
- Article
17
Design, synthesis, and computational analysis (molecular docking, DFT, MEP, RDG, ELF) of diazepine and oxazepine sulfonamides: biological evaluation for in vitro and in vivo anti-inflammatory, antimicrobial, and cytotoxicity predictions.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2367, doi. 10.1007/s11030-024-10996-5
- By:
- Publication type:
- Article
18
Exploring potential biomarkers and lead molecules in gastric cancer by network biology, drug repurposing and virtual screening strategies.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2341, doi. 10.1007/s11030-024-10995-6
- By:
- Publication type:
- Article
19
Larvicidal activity, molecular docking, and molecular dynamics studies of 7-(trifluoromethyl)indolizine derivatives against Anopheles arabiensis.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2323, doi. 10.1007/s11030-024-10994-7
- By:
- Publication type:
- Article
20
Taiwan Chingguan Yihau may improve post-COVID-19 respiratory complications through PI3K/AKT, HIF-1, and TNF signaling pathways revealed by network pharmacology analysis.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2305, doi. 10.1007/s11030-024-10993-8
- By:
- Publication type:
- Article
21
Design, synthesis, and nematicidal activity of novel 1,2,4-oxadiazole derivatives containing amide fragments.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2293, doi. 10.1007/s11030-024-10992-9
- By:
- Publication type:
- Article
22
Discovery and optimization of 4-(imidazo[1,2-a]pyrimidin-3-yl)thiazol-2-amine derivatives as novel phosphodiesterase 4 inhibitors.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2283, doi. 10.1007/s11030-024-10991-w
- By:
- Publication type:
- Article
23
Comprehensive investigation of network pharmacology, computational modeling, and pharmacokinetic assessment to evaluate the efficacy of flavonoids in rheumatoid arthritis.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2265, doi. 10.1007/s11030-024-10989-4
- By:
- Publication type:
- Article
24
Repurposing FDA-approved drugs for combating tigecycline resistance in Acinetobacter baumannii: in silico screening against BaeR protein.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2243, doi. 10.1007/s11030-024-10988-5
- By:
- Publication type:
- Article
25
Pyroptosis and chemical classification of pyroptotic agents.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2765, doi. 10.1007/s11030-024-10987-6
- By:
- Publication type:
- Article
26
A network pharmacology-based approach to understand the mechanism of action of anti-mycobacterial activity of Acacia nilotica: a modelling and experimental study.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2227, doi. 10.1007/s11030-024-10985-8
- By:
- Publication type:
- Article
27
Design, synthesis, bioactivity and action mechanism of N-substituted N′-phenylpicolinohydrazides against phytopathogenic fungi.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2209, doi. 10.1007/s11030-024-10984-9
- By:
- Publication type:
- Article
28
Microwave-assisted protocol towards synthesis of heterocyclic molecules: a comparative analysis with conventional synthetic methodologies (years 2019–2023): a review.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2717, doi. 10.1007/s11030-024-10981-y
- By:
- Publication type:
- Article
29
Ligand and structure-based virtual screening approaches in drug discovery: minireview.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2799, doi. 10.1007/s11030-024-10979-6
- By:
- Publication type:
- Article
30
An overview: total synthesis of arborisidine, and arbornamine.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2783, doi. 10.1007/s11030-024-10978-7
- By:
- Publication type:
- Article
31
Flavonol derivatives containing piperazine and quinoxaline fragments: synthesis and antifungal activity.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2193, doi. 10.1007/s11030-024-10977-8
- By:
- Publication type:
- Article
32
Environmental pollutant Di-(2-ethylhexyl) phthalate induces asthenozoospermia: new insights from network toxicology.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2179, doi. 10.1007/s11030-024-10976-9
- By:
- Publication type:
- Article
33
Synthesis, crystal structure, Hirshfeld surface, computational and biological studies of spiro-oxindole derivatives as MDM2-p53 inhibitors.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2157, doi. 10.1007/s11030-024-10974-x
- By:
- Publication type:
- Article
34
Synthesis and biological evaluation of sulfonamide derivatives containing imidazole moiety as ALK5 inhibitors.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2143, doi. 10.1007/s11030-024-10973-y
- By:
- Publication type:
- Article
35
Studies on the synthesis, crystal structures, biological activities and molecular docking of novel natural methylxanthine derivatives containing piperazine moiety.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2129, doi. 10.1007/s11030-024-10972-z
- By:
- Publication type:
- Article
36
Novel derivatives of capsaicin as a potent hypolipidemic and anti-obesity agent.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2117, doi. 10.1007/s11030-024-10971-0
- By:
- Publication type:
- Article
37
(-)-Epicatechin metabolites as a GPER ligands: a theoretical perspective.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2099, doi. 10.1007/s11030-024-10968-9
- By:
- Publication type:
- Article
38
Gene network analysis combined with preclinical studies to identify and elucidate the mechanism of action of novel irreversible Keap1 inhibitor for Parkinson's disease.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2081, doi. 10.1007/s11030-024-10965-y
- By:
- Publication type:
- Article
39
Advancements in targeting tumor suppressor genes (p53 and BRCA 1/2) in breast cancer therapy.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2691, doi. 10.1007/s11030-024-10964-z
- By:
- Publication type:
- Article
40
Current advances in the structure–activity relationship (SAR) analysis of the old/new 18-kDa translocator protein ligands.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2639, doi. 10.1007/s11030-024-10963-0
- By:
- Publication type:
- Article
41
Synthesis, biological activities and mechanistic studies of C<sub>20</sub>-ketone pachysandra alkaloids as anti-hepatocellular carcinoma agents.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2617, doi. 10.1007/s11030-024-10961-2
- By:
- Publication type:
- Article
42
Inhibition of monoamine oxidases and neuroprotective effects: chalcones vs. chromones.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2063, doi. 10.1007/s11030-024-10959-w
- By:
- Publication type:
- Article
43
Computational drug repositioning for IL6 triggered JAK3 in rheumatoid arthritis using FDA database.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2049, doi. 10.1007/s11030-024-10958-x
- By:
- Publication type:
- Article
44
Design, synthesis, and antifungal activity of novel pyrazole carboxamide derivatives containing benzimidazole moiety as potential SDH inhibitors.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2033, doi. 10.1007/s11030-024-10957-y
- By:
- Publication type:
- Article
45
Defect-engineered indium–organic framework displays the higher CO<sub>2</sub> adsorption and more excellent catalytic performance on the cycloaddition of CO<sub>2</sub> with epoxides under mild conditions.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2017, doi. 10.1007/s11030-024-10956-z
- By:
- Publication type:
- Article
46
Design, synthesis, biological evaluation and in silico study of N-(Pyrimidin-2-yl)alkyl/arylamide derivatives as quorum sensing inhibitors against Pseudomonas aeruginosa.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2001, doi. 10.1007/s11030-024-10955-0
- By:
- Publication type:
- Article
47
Synthesis of novel 4-substituted isatin Schiff base derivatives as potential autophagy inducers and evaluation of their antitumour activity.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 1983, doi. 10.1007/s11030-024-10954-1
- By:
- Publication type:
- Article
48
Natural product-derived ALK inhibitors for treating ALK-driven lung cancers: an in silico study.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 1969, doi. 10.1007/s11030-024-10953-2
- By:
- Publication type:
- Article
49
Discovery of novel 4-trifluoromethyl-2-anilinoquinoline derivatives as potential anti-cancer agents targeting SGK1.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 1945, doi. 10.1007/s11030-024-10951-4
- By:
- Publication type:
- Article
50
Identification of potential NUDT5 inhibitors from marine bacterial natural compounds via molecular dynamics and free energy landscape analysis.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 1929, doi. 10.1007/s11030-024-10950-5
- By:
- Publication type:
- Article